Lisdexamfetamine is a stimulant medication that increases the availability of two key chemical messengers in the brain: dopamine and norepinephrine. It’s approved for treating ADHD in people aged 6 and older, and for moderate to severe binge eating disorder in adults. Sold under the brand name Vyvanse, it’s designed as an inactive “prodrug” that your body must convert before it starts working, which gives it a smoother, longer-lasting effect than many other stimulants.
How It Works in the Body
Lisdexamfetamine is inactive when you swallow it. The molecule is essentially dextroamphetamine (the active drug) bonded to an amino acid called lysine. After you take it, enzymes inside your red blood cells strip away the lysine, gradually releasing dextroamphetamine into your bloodstream. This conversion happens at a steady pace, which is why the drug produces a smooth ramp-up rather than a sudden spike.
Once the active dextroamphetamine reaches your brain, it does several things at once. It blocks the transporters that normally pull dopamine and norepinephrine back into nerve cells, letting those chemicals stay active longer in the gaps between neurons. It also pushes more dopamine out of its storage compartments inside nerve cells and slows down the enzymes that break dopamine and norepinephrine apart. The net result is a significantly higher concentration of both chemicals available to stimulate the next neuron in the chain.
This matters because dopamine and norepinephrine are central to attention, motivation, impulse control, and the brain’s reward system. In ADHD, these signaling pathways are underactive, so amplifying them helps restore more typical levels of focus and self-regulation.
Why It’s Designed as a Prodrug
The prodrug structure is deliberate. With immediate-release stimulants, blood levels of the active drug can spike quickly, producing a rush that carries higher abuse potential. Lisdexamfetamine avoids that pattern because the body can only cleave off the lysine at a limited rate. Even if someone crushes and snorts the capsule or dissolves it for injection, the conversion speed doesn’t change. The drug simply cannot release dextroamphetamine any faster than red blood cell enzymes allow. This absence of a sharp early spike in concentration is the primary reason lisdexamfetamine carries a lower abuse risk compared to immediate-release dextroamphetamine formulations.
Onset, Peak, and Duration
After you take a dose, the inactive prodrug reaches its highest blood concentration in about one hour, then drops off quickly as it’s converted. The active dextroamphetamine peaks around 4.4 hours after the dose, with a half-life of roughly 12.7 hours. In practical terms, most people notice effects beginning within one to two hours of their morning dose, with the medication providing coverage across a full school or work day. Because the active compound lingers for many hours, a single morning dose is typically enough.
ADHD Treatment
For ADHD, the starting dose is 30 mg once daily, taken in the morning. From there, it can be adjusted in 10 or 20 mg steps each week until symptoms improve, up to a maximum of 70 mg per day. The medication helps with sustained attention, reduces impulsive behavior, and makes it easier to organize and follow through on tasks. These effects stem directly from the increased dopamine and norepinephrine activity in the prefrontal cortex, the brain region most responsible for planning and self-control.
Binge Eating Disorder Treatment
Lisdexamfetamine is the only stimulant medication approved specifically for moderate to severe binge eating disorder in adults. It is not approved for weight loss. The starting dose is the same 30 mg, but the target dose is higher: 50 to 70 mg per day, reached by increasing in 20 mg increments weekly.
Clinical trials show substantial reductions in binge episodes. In one study, participants on 70 mg went from an average of 4.6 binge eating days per week down to 0.5 days per week after 11 weeks. A longer study found that after 38 weeks, the average dropped from 4.8 days per week to nearly zero (0.08 days). A third trial showed a decrease from 4.3 to 0.9 binge days per week over 12 weeks. All of these reductions were statistically significant. The mechanism likely involves the same dopamine pathways, helping regulate the reward-driven compulsion that drives binge episodes.
Common Side Effects
The most frequently reported side effects overlap between the two approved uses but differ slightly in emphasis. For ADHD patients (children, adolescents, and adults), the most common reactions occurring at meaningful rates include decreased appetite, insomnia, dry mouth, anxiety, irritability, dizziness, nausea, upper abdominal pain, diarrhea, vomiting, and weight loss. For adults with binge eating disorder, the profile shifts slightly: dry mouth, insomnia, decreased appetite, increased heart rate, constipation, feeling jittery, and anxiety are the most common.
Appetite suppression is one of the most noticeable effects, and it tends to be strongest in the first few weeks before the body adjusts somewhat. Insomnia is usually related to taking the medication too late in the day, which is why morning dosing is standard.
Effects on Heart Rate and Blood Pressure
Because lisdexamfetamine increases norepinephrine activity, it has mild but measurable cardiovascular effects. In adults, lisdexamfetamine raises diastolic blood pressure (the bottom number) by an average of about 3 mmHg compared to placebo. Heart rate also increases modestly. For most healthy people, these changes are clinically insignificant, but they’re relevant for anyone who already has high blood pressure, heart disease, or other cardiovascular concerns. Children and adolescents show similar small increases.
Generic Availability and Supply
Generic versions of lisdexamfetamine capsules entered the market after Vyvanse’s patent exclusivity ended. Multiple manufacturers now produce them, including Takeda (which still makes the brand-name Vyvanse), Rhodes, Sun Pharma, Teva, and others. However, supply has been inconsistent. Several manufacturers have reported shortages or limited allocation due to active ingredient supply issues and other factors. If your pharmacy is out of one manufacturer’s version, another may be available, so it’s worth calling around or asking your pharmacist to check alternative suppliers.